前沿论文｜CELL INTELLIGENCE

Generation of an anti-CD5 CAR knock-in human induced pluripotent stem cell line using CRISPR/Cas9 technology.

PubMed 2025/05/06 发表Stem Cell ResQ4 · IF 0.6（JCR 2025）

CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

PubMed 2024/07/19 发表Sci ImmunolQ1 · IF 16.4（JCR 2025）

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.

PubMed 2022/03/25 发表Signal Transduct Target TherQ1 · IF 81.2（JCR 2025）

前沿论文 3